Successful Biotech M&A Advisory Services
3P Biopharmaceuticals engaged the experts at PharmaBioSource, Inc. as consultants and advisors to raise 6M Euros to support the growth of the company.
3P Bio is a biologics API contract manufacturing organization (CMO) located in Pamplona, Spain. 3P Bio was seeking funding to support the expansion of its mammalian cell culture and microbial fermentation development capabilities and reactor capacity within its 50,000 SF facility.
To assist 3P Bio with its goal of raising financing to support its capital requirements, PharmaBioSource engaged the biologics contract manufacturing and healthcare investment communities to identify an appropriate partner.
We utilized our expertise and extensive contacts within the biologics CMO and Life Sciences Industry to identify a number of potential partners for 3P Bio.
Services provided by the PharmaBioSource team:
PharmaBioSource, Inc. identified Infarco, the parent company of Cinfa and one of Spain’s largest generic pharmaceutical companies, as the investment partner for 3P Bio. Cinfa invested 6M Euros through a joint venture with 3P Bio to develop biosimilar products.